Vystar Corporation is an innovative biotech/specialty chemical company. Vystar has developed a patented process to chemically treat natural rubber latex ("NRL") to produce a virtually non-allergenic NRL, which the Company calls "Vytex". Vystar is the exclusive owner of this innovative Vytex technology which has application to more than 40,000 different products around the world using volumes of more than 1.25 million metric tons of liquid NRL, and having more than $3.25 billion wholesale raw material market value. The Vytex technology reduces allergenic protein in NRL products to virtually undetectable levels in both liquid NRL and finished latex products such as medical gloves and condoms.More...
Vystar Corporation
